Based on the LSPN, lncRNA-SNP mediated ceRNA network, and by considering knowledge relating to the pathogenesis of MG, we identified six high-risk genes (BCL2, KRAS, MAPK14, VEGFA, RAF1, ESR1) and for risk pathways for MG. This evidence concerns the gene BCL2 and myasthenia gravis.